These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy? Lee DH; Linker RA Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461 [TBL] [Abstract][Full Text] [Related]
26. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis. Gonçalves ED; Souza PS; Lieberknecht V; Fidelis GS; Barbosa RI; Silveira PC; de Pinho RA; Dutra RC Autoimmunity; 2016; 49(2):132-42. PubMed ID: 26703077 [TBL] [Abstract][Full Text] [Related]
27. Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Elieh-Ali-Komi D; Cao Y Clin Rev Allergy Immunol; 2017 Jun; 52(3):436-445. PubMed ID: 28025778 [TBL] [Abstract][Full Text] [Related]
29. The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis. Hafler DA J Clin Invest; 1999 Sep; 104(5):527-9. PubMed ID: 10487765 [No Abstract] [Full Text] [Related]
30. The role of cytokines in experimental autoimmune encephalomyelitis. Bettelli E; Nicholson LB Arch Immunol Ther Exp (Warsz); 2000; 48(5):389-98. PubMed ID: 11140466 [TBL] [Abstract][Full Text] [Related]
31. Hormonal factors in susceptibility to multiple sclerosis. Duquette P; Girard M Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):195-201. PubMed ID: 8481563 [TBL] [Abstract][Full Text] [Related]
34. Signaling pathways and therapeutic perspectives related to environmental factors associated with multiple sclerosis. Tiwari S; Lapierre J; Ojha CR; Martins K; Parira T; Dutta RK; Caobi A; Garbinski L; Ceyhan Y; Esteban-Lopez M; El-Hage N J Neurosci Res; 2018 Dec; 96(12):1831-1846. PubMed ID: 30204260 [TBL] [Abstract][Full Text] [Related]
35. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Abdul-Majid KB; Stefferl A; Bourquin C; Lassmann H; Linington C; Olsson T; Kleinau S; Harris RA Scand J Immunol; 2002 Jan; 55(1):70-81. PubMed ID: 11841694 [TBL] [Abstract][Full Text] [Related]
36. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis. Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811 [TBL] [Abstract][Full Text] [Related]
37. The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies. Racke MK Curr Opin Neurol; 2008 Apr; 21 Suppl 1():S9-S18. PubMed ID: 18388801 [TBL] [Abstract][Full Text] [Related]
39. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Raine CS Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955 [No Abstract] [Full Text] [Related]
40. Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice. Bing SJ; Ha D; Hwang I; Park E; Ahn G; Song JY; Jee Y Am J Chin Med; 2016; 44(6):1099-1110. PubMed ID: 27627913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]